Table 3. Difference (Diff) of serum levels of biomarkers at 24 hours between the survivors and non-survivors.
| Survivors (n = 40) | Non-survivors (n = 23) | P value | |
|---|---|---|---|
| MCP-1_Diff (pg/mL) | −1687.71 ± 4100.62 | 792.35 ± 4253.81 | 0.026 |
| NT-Pro-BNP_Diff(pg/mL) | 532.10 ± 2038.37 | 3669.49 ± 8694.62 | 0.102 |
| S100B_Diff(pg/mL) | −31.36 ± 990.35 | 367.51 ± 1347.68 | 0.183 |
| Thrombomodulin_Diff(pg/mL) | −1888.76 ± 8800.74 | 1176.24 ± 9761.07 | 0.206 |
| LOX-1_Diff(ng/mL) | 1.28 ± 16.78 | −5.09 ± 27.70 | 0.259 |
| IL-8_Diff (pg/mL) | −135.16 ± 738.90 | 50.93 ± 449.96 | 0.278 |
| IL-6_Diff (pg/mL) | −173.19 ± 7163.20 | 1643.20 ± 5113.34 | 0.291 |
| EN-RAGE_Diff(ng/mL) | −80.72 ± 509.68 | 19.62 ± 96.86 | 0.355 |
| PAI-1_Diff(ng/mL) | −4.83 ± 38.49 | 5.93 ± 56.38 | 0.372 |
| IL-1Ra_Diff (pg/mL) | −206.31 ± 678.80 | −94.35 ± 168.57 | 0.441 |
| IL-1β_Diff (pg/mL) | −22.35 ± 129.54 | −1.69 ± 7.69 | 0.449 |
| Adiponectin_Diff(ng/mL) | −235.93 ± 414.12 | −167.85 ± 340.85 | 0.506 |
| MPO_Diff(ng/mL) | −459.50 ± 2178.36 | −197.12 ± 1260.59 | 0.599 |
| IL-10_Diff (pg/mL) | −657.15 ± 1855.69 | −490.86 ± 1482.96 | 0.715 |
| sRAGE_Diff(ng/mL) | −1763.83 ± 4933.16 | −1283.43 ± 5621.44 | 0.725 |
| VCAM_Diff(ng/mL) | −17.90 ± 179.30 | −29.44 ± 201.79 | 0.815 |
| Cystatin-C_Diff(ng/mL) | −990.89 ± 4443.30 | −1250.08 ± 5214.82 | 0.835 |
| sCD40L_Diff (pg/mL) | −3139.60 ± 10531.21 | −3567.89 ± 7358.57 | 0.864 |
| IFNγ_Diff (pg/mL) | −1.7464 ± 14.08 | −1.29 ± 3.47 | 0.881 |
| sIL-2Ra_Diff (pg/mL) | 0.63 ± 213.52 | 6.65 ± 78.57 | 0.897 |
| MDA-LDL_Diff(ng/mL) | −274.77 ± 1650.16 | −272.92 ± 3370.85 | 0.998 |